41,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
21 °P sammeln
  • Broschiertes Buch

This is the first book to discuss the use of medical cannabis in helping combat the opioid crisis, relieving pain, and reversing opioid addiction rates. With information presented in short chapters with bulleted content, this concise resource delivers all the information healthcare professionals need to know about non-cancer-related chronic pain, the opioid crisis, and medical cannabis. Using the most up-to-date evidence available, it examines the varied causes of chronic pain and provides a succinct overview of how cannabis can be integrated into treatment plans. Fast Facts About Medical…mehr

Produktbeschreibung
This is the first book to discuss the use of medical cannabis in helping combat the opioid crisis, relieving pain, and reversing opioid addiction rates. With information presented in short chapters with bulleted content, this concise resource delivers all the information healthcare professionals need to know about non-cancer-related chronic pain, the opioid crisis, and medical cannabis. Using the most up-to-date evidence available, it examines the varied causes of chronic pain and provides a succinct overview of how cannabis can be integrated into treatment plans. Fast Facts About Medical Cannabis and Opioids delves into the epidemiology behind chronic pain, what the endocannabinoid system is, and how it works. It examines the complex interactions of opiates, cannabinoids, and the central nervous system, and answers key questions about different types of medical cannabis to promote open, honest conversations. Above all, this handbook provides the tools for obtaining unbiased, accurate information to share with patients.
Autorenporträt
Gregory L. Smith, MD, MPH, is a former major in the U.S. Army and has had extensive experience and education in the field of cannabinoid medications. Dr. Smith consults as a scientific and medical adviser on cannabis and cannabinoid therapeutics with over a dozen companies in four countries.